Abstract:Background: Betatrophin is a novel adipokine that provokes pancreatic beta-cell proliferation and is involved in lipid metabolism. Aims: This study aims to evaluate the role of serum betatrophin in metabolic syndrome (MetS). Methods: A hospital-based, age-/gender-matched case control study was conducted. The serum betatrophin level was evaluated by enzyme linked immunosorbent assay. Serum concentrations of 12 adipokines were measured to assess their associations with serum betatrophin, using commercial Adipokine Magnetic Bead Panel kits. Statistical analyses included bivariate correlation, receiver operating characteristic (ROC) curve, and multivariate stepwise linear regression. Results: Serum betatrophin showed a higher level in MetS patients (997.36 +/- 475.92 pg/ml, p = 0.001) compared with controls (735.35 +/- 526.51 pg/ml). Compared with the lowest tertile, the highest tertile of serum betatrophin level indicated an association with higher risk of MetS (adjusted odds ratio = 3.521, 95% confidence interval [CI] [1.191-10.413], p = 0.023). ROC curve of betatrophin was developed to predict the presence of MetS (area under ROC = 0.682 [95% CI, 0.597-0.767], p < 0.001). Furthermore, betatrophin correlated with several parameters, e.g. age (r=0.286, p < 0.001), body mass index (r=0.160, p = 0.046), waist-to-hip ratio (r = 0.241, p = 0.002), high-density lipoprotein cholesterol (r=-0.167, p = 0.037), low-density lipoprotein cholesterol (r=-0.195, p = 0.015), fasting plasma glucose (r = 0.266, p = 0.001), hemoglobin A1C (r = 0.314, p < 0.001), homeostasis model assessment of insulin resistance (r = 0.272, p = 0.001), and various adipokines, e.g. resistin (r = 0.571, p < 0.001), interleukin-8 (r = 0.435, p < 0.001), tumor necrosis factor-a (r = 0.295, p = 0.011) and lipocalin-2 (r = 0.346, p = 0.003). Conclusions: This study supports that serum betatrophin plays an important role in MetS, involving the regulations of glucose and lipid metabolism and inflammation.

Relationship of Serum Betatrophin with Nonalcoholic Fatty Liver in a Chinese Population

Serum betatrophin level increased in subjects with nonalcoholic fatty liver disease

Serum Fetuin A Level is Associated with Nonalcoholic Fatty Liver Disease in Chinese Population

Association Between Serum Free Fatty Acid Levels and Nonalcoholic Fatty Liver Disease: a Cross-Sectional Study

Association Between Serum Afamin Levels with Nonalcoholic Associated Fatty Liver Disease

Serum vitamin D levels are inversely related with non-alcoholic fatty liver disease independent of visceral obesity in Chinese postmenopausal women.

Serum Fetuin B Level Increased in Subjects of Nonalcoholic Fatty Liver Disease: a Case-Control Study.

Relationship between Nonalcoholic Fatty Liver Disease and Abnormality of Glycolipid Metabolism

Serum betatrophin level increased in subjects with metabolic syndrome: a case-control study

Serum Proteomic Analysis Revealed Diagnostic Value of Hemoglobin for Nonalcoholic Fatty Liver Disease

Serum periostin is a potential biomarker for non-alcoholic fatty liver disease: a case–control study

Serum Apob Levels Independently Predict the Development of Non-Alcoholic Fatty Liver Disease: A 7-Year Prospective Study

Development and Validation of a Novel Non-Invasive Test for Diagnosing Nonalcoholic Fatty Liver Disease in Chinese Children

Serum Autotaxin in Non-Alcoholic Fatty Liver Disease in Chinese Population: A Case-Control Study

Association Between Serum Growth Hormone Levels and Nonalcoholic Fatty Liver Disease: a Cross-Sectional Study.

Study on the Relationship between Phospholipids and Nonalcoholic Fatty Liver Disease

Betaine Alleviates Nonalcoholic Fatty Liver Disease (NAFLD) Via a Manner Involving BHMT/FTO/m6A/ PGC1α Signaling.

Elevated Serum Phosphatidylcholine (16:1/22:6) Levels Promoted by Fish Oil and Vitamin D3 Are Highly Correlated with Biomarkers of Non-Alcoholic Fatty Liver Disease in Chinese Subjects.

Relationship between serum osteocalcin levels and non-alcoholic fatty liver disease in Chinese men.

Association between serum α-L-fucosidase and non-alcoholic fatty liver disease: Cross-sectional study.

Association Between Thyroid Function and Nonalcoholic Fatty Liver Disease in Euthyroid Elderly Chinese